A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer

Annals of Surgical Oncology

Volumn 15, Issue 11, 2008, Pages 3207-3215

  Holm, Neal ^a   Byrnes, Kerry ^a   Johnson, Lester ^b   Abreo, Fleurette ^a   Sehon, Kenneth ^b   Alley, Joann ^b   Meschonat, Carol ^a   Md, Quyen Chu ^a   Li, Benjamin D L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E;

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, EXTENDED RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 55149110561     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0086-9     Document Type: Article

References (49)

1. National Cancer Institute. Cancer Trends Progress Report - 2007 Update. Bethesda, MD: NIH, DHHS, December 2007. Available at: http://www.progressreport. cancer.gov. Accessed July 24, 2008
2. Greene FL, Page DL, Fleming ID, et al., eds. (2002) American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 6th edition. New York: Springer-Verlag
3. S Ogura T Hodeida Y Hozumi 2007 Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk J Surg Oncol 96 46 53
4. N Weidner B Cady WH III Goodson 1997 Pathologic prognostic factors for patients with breast carcinoma: which factors are important Surg Oncol Clin North Am 6 415 62
5. A DeBenedetti JR Graff 2004 eIF-4E expression and its role in malignancies and metastases Oncogene 23 3189 99
6. J Graff B Konicek J Carter 2008 Targeting initiation factor 4e for cancer therapy Cancer Res 68 631 4
7. Y Mamane E Petroulakis L Rong 2004 eIF4E-from translation to transformation Oncogene 23 3172 9
8. SG Zimmer A DeBenedetti JR Graff 2000 Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis Anticancer Res 20 1343 51
9. AC Gingras B Raught N Sonenberg 2001 Regulation of translation initiation by FRAP/mTOR Genes Dev 15 807 26
10. CG Kevil A DeBenedetti DK Payne 1996 Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis Int J Cancer 65 785 90
11. C Kevil P Carter B Hu 1995 Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation Oncogene 11 2339 48
12. EV Schmidt 2004 The role of c-myc in regulation of translation initiation Oncogene 23 3217 21
13. IB Rosenwald A Lazaris-Karatzas N Sonenberg 1993 Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E Mol Cell Biol 13 7358 63
14. IB Rosenwald R Kaspar D Rousseau 1995 Eukaryotic translation initiation factor 4E regulates expression of cyclin D at transcriptional and posttranscriptional levels J Biol Chem 270 21176 80
15. R Wolfort A DeBenedetti S Nuthalapaty 2006 Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer Surgery 140 161 9
16. KW Byrnes A DeBenedetti NT Holm 2007 Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E everexpression J Am Coll Surg 204 925 33
17. D Rousseau R Kaspar I Rosenwald 1996 Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E Proc Natl Acad Sci USA 93 1065 70
18. SC Thumma RA Kratzke 2007 Translational control: a target for cancer therapy Cancer Lett 258 1 8
19. R Duncan SC Milburn JB Hershey 1987 Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF4E suggest a role in translational control J Biol Chem 262 380
20. A DeBenedetti S Joshi-Barve C Rinker-Schaeffer 1991 Expression of antisense RNA against initiation factor eIF4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF4E and p220 component of eIF4F Mol Cell Biol 11 5435
21. Y Mamane E Petroulakis Y Martineau 2007 Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation PLoS ONE 2 e242
22. V Kerekatte K Smiley B Hu 1995 The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas Int J Cancer 64 27 31
23. BD Li L Liu M Dawson 1997 Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma Cancer 79 2385 90
24. PA Scott K Smith R Poulsom 1998 Differential expression of vascular endothelial growth factor mRNA vs. protein isoform expression in human breast cancer and relationship to elF-4E Br J Cancer 77 2120 8
25. BD Li JC McDonald R Nassar 1998 Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression Ann Surg 227 756 61
26. BD Li JS Gruner F Abreo 2002 Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome Ann Surg 235 732 8
27. DR McClusky Q Chu H Yu 2005 A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer Ann Surg 242 584 90
28. AJ Dickinson SB Fox RA Persad 1994 Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas Br J Urol 74 762 6
29. Bochner BH, Cote RJ, Weidner N, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995;87:1603-12
30. TM Jaeger N Weidner K Chew 1995 Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer J Urol 154 69 71
31. MF Melhem AI Meisler GG Finley 1992 Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors Cancer Res 52 5853 64
32. IB Rosenwald DB Rhoads LD Callanan 1993 Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc Proc Natl Acad Sci USA 90 6175 8
33. RM Jones J Branda KA Johnston 1996 An essential E box in the promoter of the gene encoding the mRNA cap-bindingprotein (eukaryotic initiation factor 4E) is a target foractivation by c-myc Mol Cell Biol 16 4754 64
34. CO Nathan K Sanders FW Abreo 2000 Correlation of p53 and the proto-oncogene eIF4E in larynxcancers: prognostic implications Cancer Res 60 3599 604
35. CO Nathan L Liu BD Li 1997 Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer Oncogene 15 579 84
36. CO Nathan S Franklin FW Abreo 1999 Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer J Clin Oncol 17 2909 14
37. CO Nathan N Amirghahri C Rice 2002 Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients Laryngoscope 112 2129 40
38. J Matthews-Greer G Caldito A DeBenedetti 2005 eIF4E as a marker for cervical neoplasia Appl Immunohistochem Mol Morphol 13 367 70
39. J Matthews-Greer A DeBenedetti A Tucker 2002 A model for angiogenesis in HPV-medicated cervical neoplasia J Appl Res 2 63 73
40. JW Lee JJ Choi KM Lee 2005 eIF-4E expression is associated with histopathologic grades in cervical neoplasia Hum Pathol 36 1197 203
41. AD Chapman KM Kerr 2000 The association between atypical adenomatous hyperplasia and primary lung cancer Br J Cancer 83 632 6
42. M Mori SK Rao HH Popper 2001 Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung Mod Pathol 14 72 84
43. D Ruggero L Montanaro L Ma 2004 The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis Nat Med 10 484 6
44. H Mossafa D Damotte A Jenabian 2006 Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis Leuk Lymphoma 47 1885 93
45. Y Li R Defatta G Sunavala-Doussabhoy 2001 A translationally regulated Tousled Kinase phosphorylates histone H3 and confers radioresistance when overexpressed Oncogene 20 726 38
46. Sunavala-Doussabhoy G, Balakrishnan SK, DeBenedetti A. The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks. BMC Mil Biol 2005:6-19
47. KS Norton D McClusky A Debenedetti 2004 TLK1B is elevated with eIF4E overexpression in breast cancer J Surg Res 116 98 103
48. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31
49. K Byrnes S White Q Chu 2006 High eIF4E, VEGF and microvessel density in stage I to III breast cancer Ann Surg 243 684 90